???global.info.a_carregar???
Luísa Lobato is senior nephrologist at Centro Hospitalar Universitário de Santo António (CHUdSA) and full professor of Nephrology at Instituto de Ciências Biomédicas Abel Salazar/ School of Medicine and Biomedical Sciences (ICBAS), University of Porto (UP), Portugal. She obtained her MD degree at ICBAS/UP and, in 2004, she earned the PhD in Medical Sciences from the same faculty assigning her studies in hereditary ATTR amyloidosis. She is Director of the Department of Nephrology of CHUdSA, senior clinician expert of the European Rare Kidney Disease Reference Network (ERKNet), and coordinates the kidney outpatient clinic of Unidade Corino de Andrade, the unit dedicated to hereditary amyloidosis. She is the President of Scientific Committee of Portuguese Society of Nephrology since 2022. Luísa Lobato coordinates at ICBAS the Erasmus+ mobility programmes and the cooperation agreements with Brasil. In 2023, she was selected by the European Society of Nephrology as a Mentor of Young European Nephrologists. Previously, she held the position of director of the Department of Education, Training, and Research at CHUdSA, overseeing its Clinical Trials Unit from 2013 until 2023; in that period she represented CHUdSA at PtCRIN, Portuguese Clinical Research Infrastructure Network, a distributed RI, the national node of ECRIN ERIC. She is researcher at the Unit for Multidisciplinary Research In Biomedicine/UMIB, first (2007-2017) as principal investigator of Nephrology, Dialysis & Transplantation (NDT) research group and after 2018 as its Vice-Coordinator; since 2022 she is also researcher at the Lab for Integrative and Translational Research in Population Health, UP. Major research outputs are related with hereditary ATTR amyloidosis and Fibrinogen A alpha-chain amyloidosis, with focus in its epidemiology and genotypic-phenotypic correlations. To apply a personalized medicine approach, her studies rely on real life effects of anti-amyloid therapy on ATTR kidney disease. Other research topics: allocation improvement in kidney transplantation; outcomes and trajectories of kidney function decline.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Luísa Maria Correia Lopes Lobato

Nomes de citação

  • Lobato, Luísa

Identificadores de autor

Ciência ID
B61E-6079-8F82
ORCID iD
0000-0002-1464-083X

Endereços de correio eletrónico

  • lmlobato@icbas.up.pt (Profissional)
  • luisalobato@chporto.min-saude.pt (Profissional)

Moradas

  • Department of Nephrology - Centro Hospitalar Universitário de Santo António. Largo Abel Salazar, 4099-001, Porto, Porto, Portugal (Profissional)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Clínica - Urologia e Nefrologia
  • Ciências Médicas e da Saúde - Medicina Clínica - Transplantes
  • Ciências Médicas e da Saúde - Medicina Básica - Genética Humana
  • Ciências Médicas e da Saúde - Medicina Básica - Patologia

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador independente (B2) Utilizador proficiente (C1) Utilizador independente (B2) Utilizador independente (B2)
Francês Utilizador independente (B1) Utilizador proficiente (C1) Utilizador independente (B1) Utilizador independente (B1)
Espanhol; Castelhano Utilizador elementar (A1) Utilizador independente (B1) Utilizador elementar (A1) Utilizador elementar (A1)
Formação
Grau Classificação
2016 - 2016
Concluído
 Senior Nephrologist (Outros)
Centro Hospitalar Universitário do Porto EPE, Portugal
2015/09/15 - 2015/12/20
Concluído
 PADIS (Outros)
AESE Business School, Portugal
2004/09/24
Concluído
 Medical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"A Nefropatia na Polineuropatia Amiloidótica do Tipo Português, TTR V30M" (TESE/DISSERTAÇÃO)
 Unanimidade
2002 - 2002
Concluído
 Consultant Nephrologist (Outros)
Centro Hospitalar Universitário do Porto EPE, Portugal
1989 - 1994
Concluído
 Nephrologist (Título de especialista)
Centro Hospitalar Universitário do Porto EPE, Portugal
1986/10/10
Concluído
 Licenciatura em Medicina (Licenciatura)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"n/a" (TESE/DISSERTAÇÃO)
 15 valores
Percurso profissional

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2017/09/01 - Atual Professor Catedrático Convidado (Docente Universitário) Universidade do Porto, Portugal
2007 - 2015 Professor Auxiliar Convidado (Docente Universitário) Universidade do Porto Unidade Multidisciplinar de Investigação Biomédica, Portugal
2007 - 2013 Professor Auxiliar Convidado (Docente Universitário) Universidade do Porto Unidade Multidisciplinar de Investigação Biomédica, Portugal

Outras Carreiras

Categoria Profissional
Instituição de acolhimento 		Empregador
2016/05/13 - Atual Assistente graduado sénior (Médica) Universidade do Porto Unidade Multidisciplinar de Investigação Biomédica, Portugal
2016/05/13 - Atual Assistente graduado sénior (Médica) Centro Hospitalar Universitário do Porto EPE, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Cargos e Funções

Categoria Profissional
Instituição de acolhimento 		Empregador
2022/11/26 - Atual Director of the Department of Nephrology Centro Hospitalar Universitário do Porto EPE, Portugal

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2022/01/01 - Atual President of the Scientific Committee Sociedade Portuguesa de Nefrologia, Portugal
2021/02/26 - Atual Investigador integrado ITR - Laboratory for Integrative and Translational Research in Population Health, Portugal
2017/12/30 - Atual Vice-Coordenadora da Unidade Multidisciplinar de Investigação Biomédica - UMIB Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017/01/01 - Atual Professor of Nephrology Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016/05/13 - Atual Senior Consultant of Nephrology Centro Hospitalar Universitário do Porto EPE, Portugal
2016/01/01 - Atual Strategic group PtCRIN , Portugal
2015/04/01 - Atual Scientific Committee Sociedade Portuguesa de Nefrologia, Portugal
2011/07/30 - Atual Academic Coordinator of Mobility Programmes/ Erasmus Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2004/01/01 - Atual Coordenation of Neprology outpatient clinic for Transthyretin Amyloidosis Centro Hospitalar Universitário do Porto EPE, Portugal
2000/01/02 - Atual Activity on kidney and simultaneous liver-kidney transplantation Centro Hospitalar Universitário do Porto EPE, Portugal
1998/06/01 - Atual Coordenation of clinical studies on hereditary renal amyloidosis Centro Hospitalar Universitário do Porto EPE, Portugal
1998/01/01 - Atual Research on clinical genetics and epidemiology Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
2013/07/19 - 2023/05/01 Direction of Department of Clinical Research - Clinical Trials Unit Centro Hospitalar Universitário do Porto EPE, Portugal
Centro Hospitalar Universitário do Porto EPE, Portugal
2013/07/19 - 2023/05/01 Director of the Department of Education, Training and Research Centro Hospitalar Universitário do Porto EPE, Portugal
2014/09/17 - 2022/09/20 Member of the Representatives Council Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2007/07/15 - 2017/12/31 Principal Investigator RG-Norte-215-2990 "Nephrology, Dialysis and Transplantation" from UMIB Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2003/02/28 - 2017/10/01 Assistant professor of Nephrology Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2002/06/30 - 2016/05/13 Consultant of Nephrology Centro Hospitalar Universitário do Porto EPE, Portugal
2009/10/14 - 2015/03/31 Member of the Board Ordem dos Médicos, Portugal
2015 - 2015 UniGENe Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2010/05/31 - 2014/01/01 Scientific Advisory Board for Renal Diseases Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
2007 - 2013/12/31 UniGENe Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
2006/01/01 - 2013/07/19 Head of the inpatient area of clinical nephrology and scientific manager certification process to ISO 9001: 2008 APCER Centro Hospitalar Universitário do Porto EPE, Portugal
2011 - 2013 UniGENe Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
2009/02/01 - 2011/03/30 Principal supervisor of the Experimental Examination - Access to Medical Specialities - from the National Board of Medical Examiners. Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2008 - 2009 UniGENe Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
2006/06/06 - 2008/06/06 Member of Scientific Committee of Masters in Medicine Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
1994/07/14 - 2002/10/25 Assistant of Nephrology Centro Hospitalar Universitário do Porto EPE, Portugal
1992/01/02 - 1996/12/30 Investigation on immunoadsortion therapies Centro Hospitalar Universitário do Porto EPE, Portugal
1993/10/01 - 1995/07/30 Assistant lecturer of Nephrology Centro Hospitalar Universitário do Porto EPE, Portugal
1989/01/01 - 1994/03/30 Resident of Nephrology Centro Hospitalar Universitário do Porto EPE, Portugal
1987/01/01 - 1991/12/31 Training in clinical genetics of familial amyloidotic polyneuropathy Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
1986/10/01 - 1990/01/01 Monitor of investigation – Specialty Genetics Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
1986/01/01 - 1988/07/31 Junior teaching assistant of Clinical Medicine Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Projetos

Bolsa

Designação Financiadores
2018/12 - 2020/12 Support for intelligent decision-making to improve training, research and clinical practice
POCI-05-5762-FSE-000099
 European Social Fund

Projeto

Designação Financiadores
2021/12/01 - Atual LEARN: Communicate Clinical Trials in a Pediatric Environment
AICIB 2021 (17 - CHUPorto)
Co-Investigador Responsável (Co-IR)
Centro Hospitalar Universitário do Porto EPE, Portugal
 AICIB - Agência de Investigação Clínica e Inovação Biomédica
Em curso
2021/03/06 - Atual VACCELERATE - European Corona Vaccine Trial Accelerator Platform
VACCELERATE
National implementation
Centro Hospitalar Universitário do Porto EPE, Portugal
 European Union
Em curso

Outro

Designação Financiadores
2019/09/01 - 2021/06/01 Training for professionals in the health sector
POISE
Implementação
Centro Hospitalar Universitário do Porto EPE, Portugal
 European Social Fund
2012/01/01 - 2016/01/01 Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
NCT01215747
Investigador hospitalar
Centro Hospitalar Universitário do Porto EPE, Portugal
Concluído
Produções

Publicações

Artigo em conferência
  1. Lobato, Luísa. "PROGNOSTIC ROLE OF GLOMERULAR C3 DEPOSITION IN MEMBRANOUS NEPHROPATHY". Trabalho apresentado em 37th Congress of the Portuguese Society of Nephrology, Porto, 2023.
    Publicado
  2. Lobato, Luísa. "ATTR KIDNEY DISEASE UNDER DISEASE-MODIFYING DRUGS: IMPLICATIONS OF SWITCHING THERAPY". Trabalho apresentado em 37th Congress of the Portuguese Society of Nephrology, Porto, 2023.
    Publicado
Artigo em revista
  1. Lobato, Luísa. "Clinical pharmacokinetic study of latrepirdine via in silico sublingual administration". In Silico Pharmacology 9 1 (2021): http://dx.doi.org/10.1007/s40203-021-00083-0.
    10.1007/s40203-021-00083-0
  2. Lobato, Luísa. "Eplet-based virtual PRA increases transplant probability in highly-sensitized patients.". Transplant immunology (2021): https://doi.org/10.1016/j.trim.2021.101362.
    10.1016/j.trim.2021.101362
  3. Lobato, Luísa. "Different kidney function trajectory patterns before dialysis in elderly patients: clinical implications and outcomes". Renal Failure 43 1 (2021): 1049-1059. http://dx.doi.org/10.1080/0886022x.2021.1945464.
    10.1080/0886022x.2021.1945464
  4. Lobato, Luísa. "HLA class II eplet mismatch load improves prediction of dnDSA development after living donor kidney transplantation.". International journal of immunogenetics (2020): https://doi.org/10.1111/iji.12519.
    10.1111/iji.12519
  5. Lobato, Luísa. "Improving HLA matching in living donor kidney transplantation using kidney paired exchange program.". Transplant immunology (2020): https://doi.org/10.1016/j.trim.2020.101317.
    10.1016/j.trim.2020.101317
  6. Tavares, Joana; Campos, Andreia; Rocha, Ana; Beirão, Idalina; Fonseca, Isabel; Silva, Ana; Cardoso, Márcio; et al. "P0052EMERGING CONCEPTS IN KIDNEY ATTR AMYLOIDOSIS: CHRONIC ADMINISTRATION OF TAFAMIDIS". Nephrology Dialysis Transplantation 35 Supplement (2020): http://dx.doi.org/10.1093/ndt/gfaa142.p0052.
    10.1093/ndt/gfaa142.p0052
  7. Tavares, I.; Oliveira, M.E.; Maia, N.; Moreira, L.; Castro Lacerda, P.; Santos, J.; Santos, R.; Pinho Costa, P.; Lobato, L.. "Haplotype analysis of newly diagnosed Portuguese and Brazilian families with fibrinogen amyloidosis caused by the FGA p.Glu545Val variant". Amyloid 26 sup1 (2019): 144-145. http://www.scopus.com/inward/record.url?eid=2-s2.0-85069632666&partnerID=MN8TOARS.
    10.1080/13506129.2019.1582500
  8. Santos, J.; Oliveira, P.; Malheiro, J.; Campos, A.; Correia, S.; Cabrita, A.; Lobato, L.; Fonseca, I.. "Predicting 6-Month Mortality in Incident Elderly Dialysis Patients: A Simple Prognostic Score". Kidney and Blood Pressure Research (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85076628676&partnerID=MN8TOARS.
    10.1159/000504136
  9. Tafulo, S.; Malheiro, J.; Santos, S.; Dias, L.; Almeida, M.; Martins, L.S.; Pedroso, S.; et al. "Degree of HLA class II eplet mismatch load improves prediction of antibody-mediated rejection in living donor kidney transplantation". Human Immunology 80 12 (2019): 966-975. http://www.scopus.com/inward/record.url?eid=2-s2.0-85073009895&partnerID=MN8TOARS.
    10.1016/j.humimm.2019.09.010
  10. Tavares, I.; Silvano, J.; Moreira, L.; Oliveira, M.E.; Silva, R.; Sampaio, S.; Costa, P.P.; Lobato, L.. "Short-term complications after renal transplantation in AFibE526V (p.Glu545Val) amyloidosis". Amyloid 26 sup1 (2019): 162-163. http://www.scopus.com/inward/record.url?eid=2-s2.0-85069713207&partnerID=MN8TOARS.
    10.1080/13506129.2019.1583196
  11. Lascasas, J.M.S.S.; Fonseca, I.; Malheiro, J.; Santos, S.; Campos, A.; Castro, A.; Moreira, C.; et al. "Demographic, clinical characteristics and cardiovascular disease burden in a Portuguese cohort of older chronic kidney disease patients". Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia 41 1 (2019): 29-37. http://www.scopus.com/inward/record.url?eid=2-s2.0-85065674613&partnerID=MN8TOARS.
    10.1590/2175-8239-JBN-2018-0120
  12. Tavares, Isabel; Moreira, Luciana; Costa, Paulo Pinho; Lobato, Luísa. "Fibrinogen A alpha-chain amyloidosis: a non-negligible cause of chronic kidney disease in dialysis patients". (2017): http://hdl.handle.net/10400.18/5437.
    10.1080/13506129.2017.1281119
  13. Tavares, Isabel; Oliveira, João Paulo; Pinho, Ana; Moreira, Luciana; Rocha, Liliana; Santos, Josefina; Pinheiro, Joaquim; Costa, Paulo Pinho; Lobato, Luísa. "Unrecognized Fibrinogen A a-Chain Amyloidosis: Results From Targeted Genetic Testing". (2017): http://hdl.handle.net/10400.18/5471.
    10.1053/j.ajkd.2017.01.048
  14. Lobato, Luísa. "Ensaios clínicos em crianças iniciados pelo investigador". (2017): https://revistas.rcaap.pt/nascercrescer/article/view/10796.
  15. Rocha, A.; Silva, A.; Cardoso, M.; Beirão, I.; Alves, C.; Teles, P.; Coelho, T.; Lobato, L.. "Transthyretin (ATTR) amyloidosis nephropathy: lessons from a TTR stabilizer molecule". Amyloid 24 (2017): 81-82. http://www.scopus.com/inward/record.url?eid=2-s2.0-85018792016&partnerID=MN8TOARS.
    10.1080/13506129.2016.1277697
  16. Santos, J.; Fonseca, I.; Malheiro, J.; Beirao, I.; Lobato, L.; Oliveira, P.; Cabrita, A.. "End-stage renal disease versus death in a Portuguese cohort of elderly patients: An approach using competing event analysis". Journal of Investigative Medicine 65 7 (2017): 1041-1048. http://www.scopus.com/inward/record.url?eid=2-s2.0-85030756124&partnerID=MN8TOARS.
    10.1136/jim-2017-000480
  17. Moreira, C.L.; Rocha, A.; Santos, J.; Santos, M.; Beirão, I.; Coelho, T.; Lobato, L.. "The ever-growing understanding of transthyretin amyloidosis nephropathy". Amyloid 24 (2017): 117-118. http://www.scopus.com/inward/record.url?eid=2-s2.0-85018792388&partnerID=MN8TOARS.
    10.1080/13506129.2017.1293645
  18. Rocha, A.; Lobato, L.. "Liver transplantation in transthyretin amyloidosis: Characteristics and management related to kidney disease". Transplantation Reviews 31 2 (2017): 115-120. http://www.scopus.com/inward/record.url?eid=2-s2.0-84995752428&partnerID=MN8TOARS.
    10.1016/j.trre.2016.09.002
  19. Rocha, A.; Beirão, I.; Pessegueiro, H.; Almeida, R.; Lobato, L.. "End-stage renal failure due to transthyretin amyloidosis after liver transplantation: outcomes in 19 registry cases". Amyloid 24 (2017): 85-86. http://www.scopus.com/inward/record.url?eid=2-s2.0-85018734653&partnerID=MN8TOARS.
    10.1080/13506129.2017.1278687
  20. Sousa-Martins, P.D.; Moura, A.; Madureira, J.; Alija, P.; Oliveira, J.G.; Lopez, M.; Filgueiras, M.; et al. "Risk factors for mortality in end-stage kidney disease patients under online-hemodiafiltration: three-year follow-up study". Biomarkers 21 6 (2016): 544-550. http://www.scopus.com/inward/record.url?eid=2-s2.0-84961880685&partnerID=MN8TOARS.
    10.3109/1354750X.2016.1160428
  21. Campos,Andreia; Santos,Sofia; Santos,Josefina; Malheiro,Jorge; Rodrigues,Anabela; Lobato,Luísa; Viscaíno,J. Ramón; Cabrita,António. "Mesalazine induced tubulointersticial nephritis". (2015): http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000200009.
  22. Carvalho, A.; Rocha, A.; Lobato, L.. "Liver transplantation in transthyretin amyloidosis: Issues and challenges". Liver Transplantation 21 3 (2015): 282-292. http://www.scopus.com/inward/record.url?eid=2-s2.0-84923535811&partnerID=MN8TOARS.
    10.1002/lt.24058
  23. Fonseca, I.; Reguengo, H.; Oliveira, J.C.; Martins, L.S.; Malheiro, J.; Almeida, M.; Santos, J.; et al. "A triple-biomarker approach for the detection of delayed graft function after kidney transplantation using serum creatinine, cystatin C, and malondialdehyde". Clinical Biochemistry 48 16-17 (2015): 1033-1038. http://www.scopus.com/inward/record.url?eid=2-s2.0-84947041233&partnerID=MN8TOARS.
    10.1016/j.clinbiochem.2015.07.007
  24. Fonseca, I.; Oliveira, J.C.; Santos, J.; Malheiro, J.; Martins, L.S.; Almeida, M.; Dias, L.; et al. "Leptin and adiponectin during the first week after kidney transplantation: Biomarkers of graft dysfunction?". Metabolism: Clinical and Experimental 64 2 (2015): 202-207. http://www.scopus.com/inward/record.url?eid=2-s2.0-84920664567&partnerID=MN8TOARS.
    10.1016/j.metabol.2014.10.003
  25. Tavares,Isabel; Vaz,Raquel; Moreira,Luciana; Pereira,Pedro Rodrigues; Sampaio,Susana; Vizcaino,J. Ramon; Oliveira,Joao Paulo; Costa,Paulo Pinho; Lobato,Luisa. "Renal amyloidosis: classification of 102 consecutive cases". (2014): http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-01692014000300003.
  26. Antunes,Ana L; Campos,Andreia; Santos,Sofia; Malheiro,Jorge; Aguiar,Pedro; Vizcaino,Ramon; Santos,Josefina; Lobato,Luisa; Cabrita,Antonio. "Predictive factors of dialysisdependent chronic kidney disease associated with ANCA vasculites". (2014): http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-01692014000200005.
  27. Fonseca, I.; Reguengo, H.; Almeida, M.; Dias, L.; Martins, L.S.; Pedroso, S.; Santos, J.; et al. "Oxidative stress in kidney transplantation: Malondialdehyde is an early predictive marker of graft dysfunction". Transplantation 97 10 (2014): 1058-1065. http://www.scopus.com/inward/record.url?eid=2-s2.0-84901283597&partnerID=MN8TOARS.
    10.1097/01.TP.0000438626.91095.50
  28. Rocha, S.; Carvalho, M.J.; Lobato, L.; Santos, J.; Rocha, G.; Vizcaíno, R.; Cabrita, A.. "C1q Nephropathy and Malignancy". Nefrologia 32 2 (2012): 270-272. http://www.scopus.com/inward/record.url?eid=2-s2.0-84864410359&partnerID=MN8TOARS.
    10.3265/Nefrologia.pre2011.Dec.11246
  29. Stangou, A.J.; Lobato, L.; Zeldenrust, S.; Rela, M.; Portmann, B.; Linke, R.P.; Conceicao, I.; et al. "Solid organ transplantation for non-TTR hereditary amyloidosis: Report from the 1st International Workshop on the Hereditary Renal Amyloidoses". Amyloid 19 SUPPL. 1 (2012): 81-84. http://www.scopus.com/inward/record.url?eid=2-s2.0-84861453554&partnerID=MN8TOARS.
    10.3109/13506129.2012.668503
  30. Lobato, L.; Rocha, A.. "Transthyretin amyloidosis and the kidney". Clinical Journal of the American Society of Nephrology 7 8 (2012): 1337-1346. http://www.scopus.com/inward/record.url?eid=2-s2.0-84864822864&partnerID=MN8TOARS.
    10.2215/CJN.08720811
  31. Lobato, L.; Beirão, I.; Seca, R.; Pessegueiro, H.; Rocha, M.J.; Queiroz, J.; Gomes, M.; et al. "Combined liver–kidney transplantation in familial amyloidotic polyneuropathy TTR V30M: Nephrological assessment". Amyloid 18 sup1 (2011): 190-192. http://www.scopus.com/inward/record.url?eid=2-s2.0-85027915619&partnerID=MN8TOARS.
    10.3109/13506129.2011.574354071
  32. Rocha, A.; Lobato, L.; Silva, H.; Beirão, I.; Santos, J.; Pessegueiro, H.; Almeida, R.; Cabrita, A.. "Characterization of end-stage renal disease after liver transplantation in transthyretin amyloidosis (ATTR V30M)". Transplantation Proceedings 43 1 (2011): 189-193. http://www.scopus.com/inward/record.url?eid=2-s2.0-79951786208&partnerID=MN8TOARS.
    10.1016/j.transproceed.2010.11.014
  33. Tavares, I.; Lobato, L.; Moreira, L.; Santos, J.; Lacerda, P.; Pinheiro, J.; Costa, P.. "Long-term follow-up of patients with hereditary fibrinogen A alpha-chain amyloidosis.". Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 18 Suppl 1 (2011): 216-217. http://www.scopus.com/inward/record.url?eid=2-s2.0-82255165417&partnerID=MN8TOARS.
    10.3109/13506129.2011.627069
  34. Rocha, S.; Lobato, L.; Carvalho, M.J.; Malheiro, J.; Vizcaíno, R.; Rodrigues, A.; Cabrita, A.. "Renal transplantation in AA amyloidosis associated with Whipple's disease". Amyloid 18 4 (2011): 240-244. http://www.scopus.com/inward/record.url?eid=2-s2.0-81255124266&partnerID=MN8TOARS.
    10.3109/13506129.2011.614651
  35. Fonseca, I.; Almeida, M.; Martins, L.S.; Santos, J.; Dias, L.; Lobato, L.; Henriques, A.C.; Mendonça, D.. "First-year renal function predicts long-term renal allograft loss". Transplantation Proceedings 43 1 (2011): 106-112. http://www.scopus.com/inward/record.url?eid=2-s2.0-79951781207&partnerID=MN8TOARS.
    10.1016/j.transproceed.2010.12.034
  36. Beirão, I.; Moreira, L.; Barandela, T.; Lobato, L.; Silva, P.; Gouveia, C.M.; Carneiro, F.; et al. "Erythropoietin production by distal nephron in normal and familial amyloidotic adult human kidneys". Clinical Nephrology 74 5 (2010): 327-335. http://www.scopus.com/inward/record.url?eid=2-s2.0-78649902510&partnerID=MN8TOARS.
  37. Beirão, I.; Moreira, L.; Porto, G.; Lobato, L.; Fonseca, I.; Cabrita, A.; Costa, P.M.P.. "Low erythropoietin production in familial amyloidosis TTR V30M is not related with renal congophilic amyloid deposition: A clinicopathologic study of twelve cases". Nephron - Clinical Practice 109 2 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-48249126810&partnerID=MN8TOARS.
    10.1159/000142527
  38. Beirão, I.; Lobato, L.; Moreira, L.; Costa, P.M.P.; Fonseca, I.; Cabrita, A.; Porto, G.. "Long-term treatment of anemia with recombinant human erythropoietin in familial amyloidosis TTR V30M". Amyloid 15 3 (2008): 205-209. http://www.scopus.com/inward/record.url?eid=2-s2.0-54249100410&partnerID=MN8TOARS.
    10.1080/13506120802195840
  39. Beirão, I.; Lobato, L.; Costa, P.M.P.; Fonseca, I.; Silva, M.; Bravo, F.; Cabrita, A.; Porto, G.. "Liver transplantation and anemia in familial amyloidosis ATTR V30M". Amyloid 14 1 (2007): 33-37. http://www.scopus.com/inward/record.url?eid=2-s2.0-33947645336&partnerID=MN8TOARS.
    10.1080/13506120601116476
  40. Lobato, L.. "Classification of amyloidosis,Classificação das amiloidoses". Sinapse 6 1 SUPPL. 1 (2006): 68-73. http://www.scopus.com/inward/record.url?eid=2-s2.0-33745427626&partnerID=MN8TOARS.
  41. Lobato, L.. "Nephropathy in familial amyloidotic polyneuropathy,Nefropatia na polineuropatia amiloidótica familiar". Sinapse 6 1 SUPPL. 1 (2006): 99-102. http://www.scopus.com/inward/record.url?eid=2-s2.0-33745415315&partnerID=MN8TOARS.
  42. Beirão, I.; Lobato, L.; Costa, P.M.; Fonseca, I.; Mendes, P.; Silva, M.; Bravo, F.; Cabrita, A.; Porto, G.. "Kidney and anemia in familial amyloidosis type I.". Kidney international 66 5 (2004): 2004-2009. http://www.scopus.com/inward/record.url?eid=2-s2.0-21644479059&partnerID=MN8TOARS.
    10.1111/j.1523-1755.2004.00971.x
  43. Lobato, L.; Beirão, I.; Silva, M.; Fonseca, I.; Queirós, J.; Rocha, G.; Sarmento, A.M.; Sousa, A.; Sequeiros, J.. "End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: Presentation, survival and prognostic factors". Amyloid 11 1 (2004): 27-37. http://www.scopus.com/inward/record.url?eid=2-s2.0-2542488594&partnerID=MN8TOARS.
    10.1080/13506120410001673884
  44. Lobato, L.; Beirão, I.; Silva, M.; Bravo, F.; Silvestre, F.; Guimarães, S.; Sousa, A.; Noël, L.-H.; Sequeiros, J.. "Familial ATTR amyloidosis: Microalbuminuria as a predictor of symptomatic disease and clinical nephropathy". Nephrology Dialysis Transplantation 18 3 (2003): 532-538. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037338662&partnerID=MN8TOARS.
    10.1093/ndt/18.3.532
  45. Lobato, L.. "Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M)". Journal of Nephrology 16 3 (2003): 438-442. http://www.scopus.com/inward/record.url?eid=2-s2.0-0038127264&partnerID=MN8TOARS.
  46. Lobato, L.; Ventura, A.; Beirão, I.; Miranda, H.P.; Seca, R.; Henriques, A.C.; Teixeira, M.; Sarmento, A.M.; Pereira, M.C.. "End-stage renal disease in familial amyloidosis ATTR Val30Met: A definitive indication to combined liver-kidney transplantation". Transplantation Proceedings 35 3 (2003): 1116-1120. http://www.scopus.com/inward/record.url?eid=2-s2.0-0038369025&partnerID=MN8TOARS.
    10.1016/S0041-1345(03)00331-2
  47. Carvalho, M.J.; Lobato, L.; Ventura, A.; Beirão, I.; Rocha, G.; Seca, R.; Miranda, H.P.; et al. "Remission of proteinuria following liver transplantation for familial amyloid polyneuropathy TTR Met30". Transplantation Proceedings 32 8 (2000): 2664-2666. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034536875&partnerID=MN8TOARS.
    10.1016/S0041-1345(00)01832-7
  48. Beirão, I.; Lobato, L.; Riedstra, S.; Costa, P.M.P.; Pimentel, S.; Guimarães, S.. "Ineffectiveness of dialysis in transthyretin (TTR) clearance in Familial Amyloid Polyneuropathy type I, in spite of lower stability of the TTR Met30 variant". Clinical Nephrology 51 1 (1999): 45-49. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032924669&partnerID=MN8TOARS.
  49. Beirão, I.; Lobato, L.; Guimarães, S.M.; Cardoso, P.; Costa, P.M.P.; Coelho, T.; Rocha, G.; Guimarães, S.. "Early destructive spondyloarthropathy from combined ß2-microglobulin and transthyretin Met30 amyloidosis in a dialysed patient". Nephrology Dialysis Transplantation 13 12 (1998): 3223-3225. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031758775&partnerID=MN8TOARS.
    10.1093/ndt/13.12.3223
  50. Lobato, L.; Beirão, I.; Guimarães, S.M.; Droz, D.; Guimarães, S.; Grünfeld, J.-P.; Noël, L.-H.. "Familial amyloid polyneuropathy type I (portuguese): Distribution and characterization of renal amyloid deposits". American Journal of Kidney Diseases 31 6 (1998): 940-946. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031802371&partnerID=MN8TOARS.
    10.1053/ajkd.1998.v31.pm9631837
  51. Rodrigues, A.; Pinho, L.; Lobato, L.; Queirós, A.; Castro, R.; Daniel, M.; Dias, L.; et al. "Hepatitis C virus genotypes and the influence of the induction of immunosuppression with anti-thymocyte globulin (ATG) on chronic hepatitis in renal graft recipients". Transplant International 11 SUPPL. 1 (1998): http://www.scopus.com/inward/record.url?eid=2-s2.0-0031603738&partnerID=MN8TOARS.
  52. Braga, J.; Marques, R.; Branco, A.; Gonçalves, J.; Lobato, L.; Pimentel, J.P.; Flores, M.M.; Gonçalves, E.; Jorge, C.S.. "Maternal and perinatal implications of the use of human recombinant erythropoietin". Acta Obstetricia et Gynecologica Scandinavica 75 5 (1996): 449-453. http://www.scopus.com/inward/record.url?eid=2-s2.0-0029957326&partnerID=MN8TOARS.
  53. Queiros, J.; Cabrita, A.; Maximino, J.; Lobato, L.; Silva, M.; Xavier, E.. "Central catheter for hemodialysis: Six months experience of 103 catheters". Nephrologie 15 2 (1994): 113-115. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028182248&partnerID=MN8TOARS.
Tese / Dissertação
  1. Lobato, Luísa Maria Correia Lopes; Lobato, Luisa. "A nefropatia na Polineuropatia Amiloidótica Familiar de Tipo Português (TTR V30M)". Doutoramento, 2012. http://hdl.handle.net/10216/63699.
  2. Santos, Maria Clara Costa Bonifácio Selores dos. "Envolvimento renal na esclerose tuberosa". Mestrado, 2009. http://hdl.handle.net/10316/27530.

Outros

Outra produção
  1. Investigator initiated clinical trials in children. 2016. Lobato,Luísa. http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-07542016000600001.
Atividades

Orientação

Título / Tema
Papel desempenhado 		Curso (Tipo)
Instituição / Organização
2023/10/18 - Atual Silo Mentality in the Healthcare System: impact on the organization, employees and customers
Coorientador
 Programa Doutoral em Ciências Biomédicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021/10/01 - 2022/07/06 Fibrinogen A Alpha-Chain Amyloidosis: the landscape of dialysis and kidney transplantation in patients with the FGA p.Glu545Val variant and Portuguese ancestry
Orientador
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021/10/01 - 2022/06/29 Incident hemodialysis patients: the vascular access and clinical outcomes
Orientador
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015/11/01 - 2021/07/06 HLA epitope matching for allocation improvement in kidney transplantation
Orientador
 Ciências Biomédicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016/11/01 - 2021/05/10 Chronic kidney disease in the elderly: understanding outcomes and trajectories of kidney function decline, towards an individualized care
Orientador
 Ciências Médicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019/10/01 - 2020/07/08 Application of Lipoprotein Apheresis in Drug-Resistant Nephrotic Syndrome
Orientador
 Medicina (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014/09/01 - 2018/11/05 Amiloidose por fibrinogénio: fenótipo, genótipo, tratamento e prognóstico
Orientador
 Biomedicina (Doutoramento)
Universidade do Porto, Portugal
2011/01/01 - 2015/11/01 Factors predictive of dysfunction and renal graft loss in the long term
Coorientador
 Ciências Biomédicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2005/09/01 - 2009/06/01 Renal involvement in the genesis of anemia in Portuguese type familial amyloid polyneuropathy
Coorientador
 Ciências Médicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Distinções

Prémio

2022 Best Clinical Poster - International Society of Amyloidosis
2021 Prémio Ensaios Clínicos - AICIB- Agência de Investigação Clínica e Inovação Biomédica
2015 “Prémio Sollari Allegro de Investigação Clínica”
Centro Hospitalar Universitário do Porto EPE, Portugal
2004 Prémio Fresenius
Sociedade Portuguesa de Nefrologia, Portugal
2002 Prémio Roche 2001/2002
Sociedade Portuguesa de Nefrologia, Portugal
1998 Prémio Gulbenkian para Jovens Investigadores
Fundação Calouste Gulbenkian, Portugal

Outra distinção

2016 “Junior Researcher Travel Awards”.
International Society of Amyloidosis, Estados Unidos
2016 “Poster Prize – Best posters”
International Society of Amyloidosis, Estados Unidos
2015 European Renal Association Grant - Best abract for young author
European Renal Association European Dialysis and Transplant Association, Itália
2011 "Best Work of The Congress"
Sociedade Portuguesa de Nefrologia, Portugal
2005 Melhor Apresentação XIX Congresso Português de Nefrologia na área de Nefrologia Clínica
Sociedade Portuguesa de Nefrologia, Portugal
2004 Prémio Investigação do HGSA
Centro Hospitalar Universitário do Porto EPE, Portugal
1999 Melhor Comunicção Original em Nefrologia Clínica
Sociedade Portuguesa de Nefrologia, Portugal
1997 European Renal Association Grant
European Renal Association European Dialysis and Transplant Association, Itália